Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs …

…, EL Nasonov, EF Mysler, NA da Silva… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To examine the efficacy and safety of the humanized anti–interleukin‐6 receptor
antibody tocilizumab combined with conventional disease‐modifying antirheumatic drugs (…

… guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus) …

…, F Cavalcanti, LTL Costallat, NA Da Silva… - Annals of the …, 2018 - ard.bmj.com
Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease,
represents a significant challenge for both diagnosis and treatment. Patients with SLE in …

Acute rheumatic fever: still a challenge

NA da Silva, BA de Faria Pereira - Rheumatic Disease Clinics of North …, 1997 - Elsevier
Acute rheumatic fever (ARF) continues to be a major health problem in economically developing
and developed countries. On the one hand, after years of apparently silent refuge, ARF …

Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

…, G Quintana-López, NA Da Silva… - Seminars in Arthritis and …, 2016 - Elsevier
Objective To examine hematological manifestations’ correlates and their impact on damage
accrual and mortality in SLE patients from the multiethnic, Latin American, GLADEL cohort. …

[HTML][HTML] 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis

…, MB Bertolo, MVC Freitas, NA Silva… - Revista brasileira de …, 2012 - SciELO Brasil
OBJETIVO: Elaborar recomendações para o tratamento da artrite reumatoide no Brasil.
MÉTODO: Revisão da literatura com seleção de artigos baseados em evidência e opinião de

Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort

…, A Iglesias-Gamarra, LTL Costallat, NA Da Silva… - Lupus, 2013 - journals.sagepub.com
Objectives The objective of this paper is to assess the predictors of time-to-lupus renal disease
in Latin American patients. Methods Systemic lupus erythematosus (SLE) patients (n = …

[HTML][HTML] Intestinal microbiota and active systemic lupus erythematosus: a systematic review

…, ATO Rezende, MR Fernandes, NA Silva - Advances in …, 2021 - SciELO Brasil
Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease, characterized
by being multi-systemic and, therefore, reaching various organs and affecting mainly …

[HTML][HTML] 2011 Consensus of the Brazilian Society of Rheumatology for diagnosis and early assessment of rheumatoid arthritis

…, MB Bertolo, MVC Freitas, NA Silva… - Revista Brasileira de …, 2011 - SciELO Brasil
OBJETIVO: Elaborar recomendações para o manejo da artrite reumatoide (AR) no Brasil, com
enfoque no diagnóstico e na avaliação inicial da doença. MÉTODO: Revisão da literatura …

[HTML][HTML] Rheumatic fever: update on the Jones criteria according to the American Heart Association review-2015

BÁF Pereira, AR Belo, NA Silva - Revista Brasileira de Reumatologia, 2017 - SciELO Brasil
Rheumatic fever is still currently a prevalent disease, especially in developing countries.
Triggered by a Group A β-hemolytic Streptococcus infection, the disease may affect genetically …

Predictors of remission and low disease activity state in systemic lupus erythematosus: data from a multiethnic, multinational Latin American cohort

…, E Borba, E Sato, L Costallat, NA Da Silva… - The Journal of …, 2019 - jrheum.org
Objective. To determine the predictors of remission and low disease activity state (LDAS) in
patients with systemic lupus erythematosus (SLE). Methods. Three disease activity states …